IndraLab

Statements

USP2 activates pro-degradation HSP90 ErbB2 respective therapeutic windows. 1 / 1

| 1

eidos

"Through promoting ErbB2 ubiquitylation , USP2 inhibitor is expected to augment the pro-degradation effects of HSP90 inhibitors toward ErbB2 within their respective therapeutic windows , thus eliciting potent anti-tumor effects with tolerable adverse side effects , which warrants further investigations and clinical evaluations ."

32327714

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP2 activates pro-degradation HSP90 ErbB2 respective therapeutic windows. 1 / 1

INDRA sources:

Databases

Reading